RANI
Rani Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.65
+1.51%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.91x
- Price / sales
- 15.39x
- Price / cash flow
- -3.70x
Enterprise value
- Enterprise value
- $34.0M
- EV / sales
- 6.97x
- EV / EBITDA
- -1.06x
- EV / EBIT
- -1.03x
- Market cap
- $75.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026